Liposome Longevity and Stability in Circulation: Effects on the in vivo Delivery to Tumors and Therapeutic Efficacy of Encapsulated Anthracyclines

References

• Cowens J. W., Creaven P. J., Greco W. R., Brenner D. E., Yung T., Ostro M., Pilkiewicz P., Ginsberg R., Petrelli N. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res. (1993); 53: 2796–2802
   PubMed Web of Science ®Google Scholar
• Forssen E. A., Coulter D. M., Proffitt R. T. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid rumors. Cancer Res. (1992); 52: 3255
   PubMed Web of Science ®Google Scholar
• Gabizon A., Trainin N. Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice. Br. J. Cancer (1980); 42: 551–558
   PubMed Web of Science ®Google Scholar
• Gabizon A., Dagan A., Goren D., Barenholz Y., Fuks Z. Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. (1982); 42: 4734–4739
   PubMed Web of Science ®Google Scholar
• Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by rumors. Proc. Natl. Acad. Sri. USA (1988); 85: 6949–6953
   PubMed Web of Science ®Google Scholar
• Gabizon A., Price D. C., Huberty J., Bresalier R. S., Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental rumors: biodistribution and imaging studies. Cancer Res. (1990); 50: 6371–6378
   PubMed Web of Science ®Google Scholar
• Gabizon A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. (1992); 52: 891–896
   PubMed Web of Science ®Google Scholar
• Gabizon A., Barenholz Y., Bialer M. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethyleneglycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharm. Res. (1993); 10: 703–708
   PubMed Web of Science ®Google Scholar
• Gabizon A. Liposomal anthracyclines. Hematol. Oncol. Clin. North Am. (1994); 8: 431–450
   PubMed Web of Science ®Google Scholar
• Gill P. S., Espina B. M., Muggia F., Cabriales S., Tulpule A., Esplin J. A., Liebman H. A., Forssen E., Ross M. E., Levine A. M. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J. Clin. Oncol. (1995); 13: 996–1003
   PubMed Web of Science ®Google Scholar
• Haran G., Cohen R., Bar L. K., Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta (1993); 1151: 201–215
   PubMed Web of Science ®Google Scholar
• Harrison M., Tomlinson D., Stewart S. Liposomal-entrapped doxorubicin: An active agent in AIDS-related Kaposi's sarcoma. J. Clin. Oncol. (1995); 13: 914–920
   PubMed Web of Science ®Google Scholar
• Huang S. K., Lee K. D., Hong K., Friend D. S., Papahadjopoulos D. Microscopic localization of sterically-stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. (1992a); 52: 5135–5143
   PubMed Web of Science ®Google Scholar
• Huang S. K., Mayhew E., Gilani S., Lasic D. D., Martin F. J., Papahadjopoulos D. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. (1992b); 52: 6774–6781
   PubMed Web of Science ®Google Scholar
• Lasic D. D., Martin F. J., Gabizon A., Huang S. K., Papahdjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta (1991); 2070: 187–192
   Google Scholar
• Lichtenberg D., Barenholz Y. Liposomes: Preparation, characterization and preservation. Methods of Biochemical Analysis, D. Glick. Wiley, New York (1988); 337–463, 33
   Google Scholar
• Marks T. A., Woodman R. J., Geran R. I., Billups L. H., Madison R. M. Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents. Cancer Treat. Rep. (1977); 61: 1459–1470
   PubMedGoogle Scholar
• Mayer L. D., Bally M. B., Hope M. J., Cullis P. R. Uptake of antineoplastic agents into large unilamellar vesicles in response to membrane potential. Biochim. Biophys. Acta (1985); 816: 294–302
   PubMed Web of Science ®Google Scholar
• Mayer L. D., Tai L. C., Ko D. S., Masin D., Ginsberg R. S., Cullis P. R., Bally M. B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. (1989); 49: 5922–5930
   PubMed Web of Science ®Google Scholar
• Mayhew E. G., Lasic D. D., Babbar S., Martin F. J. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes. Int. J. Cancer (1992); 51: 302–309
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D., Allen T., Gabizon A., Mayhew E., Matthay K., Huang S. K., Lee K. D., Woodle M. C., Lasic D. D., Redemann C., Martin F. J. Sterically stabilized liposomes: improvements in pharmacokinetics and anti-tumor therapeutic efficacy. Proc. Natl. Acad. Sci U.S.A. (1991); 88: 11460–11464
   PubMed Web of Science ®Google Scholar
• Storm G., Van Bloois L., Brouwer M., Crommelin D. J. The interaction of cytostatic drugs with adsorbents in aqueous media-The potential implications for liposome preparation. Biochim. Biophys. Acta (1985); 818: 343–351
   PubMed Web of Science ®Google Scholar
• Uziely B., Jeffers S., Isacson R., Kutsch K., Wei-Tsao D., Yehoshua Z., Muggia F. M., Gabizon A. Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol. (1995); 13: 1777–1785
   PubMed Web of Science ®Google Scholar
• Vaage J., Mayhew E., Lasic D., Martin F. J. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long-circulating liposomes. Int. J. Cancer (1992); 52: 942–948
   Google Scholar
• Williams S. S., Alosco T. R., Mayhew E., Lasic D. D., Martin F. J., Bankert R. B. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Res. (1993); 53: 3964–3967
   PubMed Web of Science ®Google Scholar
• Yuan F., Leunig M., Huang S. K., Berk D. A., Papahadjopoulos D., Jain R. K. Microvascular and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. (1994); 54: 3352–3356
   PubMed Web of Science ®Google Scholar